Cite

    Ollech, J. et al. (2020). Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis. Alimentary pharmacology & therapeutics. 51 (6), pp. 637-643. [Online].